Results 141 to 150 of about 98,888 (254)

PFAS Vadose Zone Mass Discharge at an AFFF‐Impacted Site: 1. Validation Based on a Multiple Lines‐of‐Evidence Approach

Remediation Journal, Volume 36, Issue 2, Spring 2026.
ABSTRACT Questions have recently been raised about the suitability of using porewater samples collected with suction lysimeters to estimate per‐ and polyfluoroalkyl substances (PFAS) mass discharge in the vadose zone. Multiple lines of evidence were evaluated to determine if porewater samples collected during a data gaps investigation in the former ...
Grant R. Carey, David T. Adamson, Rita K. Krebs, Mia Rebeiro‐Tunstall, Kevin G. Mumford, Bo Guo, Gabriel T. Carey, Kiera Rooney, Sabrina Moga   +8 more
wiley   +1 more source

Wallace's pARCs—Making Climate, Climate Change and Biodiversity Data Available to Protected Area Managers and Conservation Planners With an Example From Biebrza National Park, Poland

Climate Resilience and Sustainability, Volume 5, Issue 1, June 2026.
A spatial representation of the potential ‘adaptation effort’ that might be needed to maintain at least 75% of the species modelled in Biebrza National Park, Poland (white outline), at 1.5°C. The darker the green shading, the less adaptation would be needed.
Jeff Price, Nicole Forstenhäusler, Erin M. Graham, Timothy J. Osborn, Rachel Warren   +4 more
wiley   +1 more source

A multi-method analysis of employee-driven green service innovation in hotels based on the ability-motivation-opportunity framework. [PDF]

Sci Rep
Li Y, Li T, Ling Y, Feng X, Wang H, Liao C.   +5 more
europepmc   +1 more source

Ecotoxicological Evaluation of Organic Sunscreens Used Worldwide, Alone and in Mixture, on Terrestrial Plants

Environmental Toxicology, Volume 41, Issue 5, Page 257-269, May 2026.
ABSTRACT The environmental hazards of sunscreens are discussed worldwide. However, there are few ecotoxicological studies on these compounds alone for edaphic organisms, and none for their mixtures. Avobenzone (1 and 10 ng/L), octocrylene (10 and 100 μg/L), and oxybenzone (2 and 20 μg/L), alone and in binary combinations (between the lowest and the ...
Diego Espirito Santo, Edson Araújo de Almeida, Elisângela Dusman, A. C. Downs, Regiane da Silva Gonzalez, Osvaldo Valarini Junior, Ana Paula Peron   +6 more
wiley   +1 more source

Gully erosion in India: Geo‐environmental controls and region‐specific characteristics

Geographical Research, Volume 64, Issue 2, May 2026.
Spatial statistical analyses using a novel spatial database of India‧s gully erosion landforms revealed that India has six major gullying‐affected regions, three of which (EU, DU, and KCH) are dominated by gully systems (gully networks), with badlands (vast intensely gullied landscapes) being predominant in the other three regions (YB, GP, and RU ...
Anindya Majhi, Martin Evans, Emma Shuttleworth, Angela Harris   +3 more
wiley   +1 more source

Hybrid Skeleton-Based Motion Templates for Cross-View and Appearance-Robust Gait Recognition. [PDF]

J Imaging
Nunes JF, Moreira PM, Tavares JMRS.
europepmc   +1 more source

Contrasting Effects of Chronic Glucokinase Activation and Inhibition on Pancreatic Beta‐Cell Function

The FASEB Journal, Volume 40, Issue 7, 15 April 2026.
In the non‐diabetic beta‐cell (top left) activation of glucokinase (bottom left) leads to inhibition of mitochondrial metabolism and thereby impairs insulin secretion. The effect is similar to that of chronic hyperglycaemia as seen in the diabetic beta‐cell (top right).
Matthew Lloyd, Natascia Vedovato, Samuel J. Mullan, Alice Elphick, Aerin J. Dumenil, Chantal Rufer, Alexandra C. Title, Burcak Yesildag, Elizabeth Haythorne, Frances M. Ashcroft   +9 more
wiley   +1 more source

Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells. [PDF]

J Exp Clin Cancer Res
Sabol HM, Paxton BC, Anloague A, Kaur J, Nester MR, Khan S, Smith J, Croucher PI, McDonald MM, Montgomery CO, Stambough JB, Barnes CL, Ambrogini E, Ebetino FH, Schinke C, Ashby C, Delgado-Calle J.   +16 more
europepmc   +1 more source

PharmVar GeneFocus: NAT2—Genetic Variation and Updated Nomenclature

Clinical Pharmacology &Therapeutics, Volume 119, Issue 4, Page 859-871, April 2026.
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human N‐acetyltransferase 2 (NAT2) gene. NAT2 metabolizes several clinically used drugs including isoniazid, hydralazine, amifampridine, procainamide, and sulfonamides such as dapsone, and also some highly carcinogenic arylamines.
Georgia Papanikolaou, Estella S. Poloni, José A.G. Agúndez, Raquel L.F. Teixeira, Erin C. Boone, Adalberto Rezende Santos, Michelle Whirl‐Carrillo, Katrin Sangkuhl, Teri E. Klein, Mariam R. Habil, Giannoulis Fakis, Rodney F. Minchin, David W. Hein, Sotiria Boukouvala, Andrea Gaedigk   +14 more
wiley   +1 more source

Role of photobiomodulation in controlling the gag reflex during posterior tooth extraction, a pilot case series. [PDF]

Lasers Med Sci
Yılmaz ZÇ, Güldiken İN, Tekin A, Daştan HK, Düç B.   +4 more
europepmc   +1 more source